ArticleInternational journal of pediatrics2026
Epidemiology and Characterization of Immunological Disorders in Children Diagnosed With Pneumococcal Invasive Disease.
Article in International journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: A substantial proportion of children hospitalized with invasive pneumococcal infection are subjected to immune evaluations, to detect immunological disorders (ID). The literature lacks thorough analysis of the necessity and effectiveness of these evaluations for previously healthy children with such infections. We aimed to examine the occurrence and characteristics of ID in children hospitalized with invasive pneumococcal disease (IPD), and to assess when immune investigations are most effective. Methods: In a retrospective study, we examined the immunological assessments and outcomes of children with IPD admitted during 2010-2023 to Schneider Children's Medical Center. Results: Out of 219 children with IPD, 144 previously healthy patients were included, with a mean age of 2.2 years and an average hospital stay of 9 days. Immunological evaluations, defined as any immune-related assessment, were performed in 94 patients (65.3%) and were not uniform across the cohort. ID were identified in 15 of 144 children (10.4%), corresponding to 15 of 94 evaluated patients (15.9%). Functional hyposplenism was the most frequent finding. No clinical or laboratory features reliably distinguished those with ID. Conclusion: Immunological evaluation should be considered in previously healthy children diagnosed with IPD. Functional hyposplenism should be considered when routine immunological evaluation is unrevealing; however, the role of universal spleen scintigraphy requires further prospective evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.